glp 1 weight loss studies Healthy maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial What are GLP-1s? | Mendinground

Headlines about Ozempic Vulva are bringing attention to a very real concern many women face after rapid weight loss

Obesity affects 42% of adults in the United States and is strongly associated with major cardiovascular disease risk factors, including high blood pressure, abnormal cholesterol levels, and insulin resistance, making effective obesity treatment a critical public health priority.

Lilly plans regulatory submissions in 2025 for obesity and in 2026 for type 2 diabetes

Dual-peptide metabolic regulation research blend

The agency said the new program, made possible by Medicare Part D, begins on July 1 and will extend until the end of 2027

Sermorelin boosts the natural production of human growth hormone, which may benefit women entering perimenopause and menopause